Scarica l'app Stockscreener
6.56
0.00%
0.00
Dopo l'orario di chiusura:
6.57
0.01
+0.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Optimizerx Corp Borsa (OPRX) Ultime notizie
OptimizeRx (OPRX) soars 5.9%: Is further upside left in the stock? - msn.com
Are Investors Undervaluing OptimizeRx (OPRX) Right Now? - qz.com
If You Invested $1,000 in Optimizerx Corp (OPRX) - Stock Titan
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now? - msn.com
OptimizeRx (OPRX) price target decreased by 40.41% to 14.79 - msn.com
New Top-Rated Stocks to Buy for April 1st - Bitget
OPRX Should I Buy - Intellectia AI
OptimizeRx (NASDAQ: OPRX) switches auditors from UHY LLP to Grant Thornton - Stock Titan
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - marketbeat.com
Vanguard disaggregates holdings; OPRX parent reports 0 shares (OPRX) - Stock Titan
OPRX Technical Analysis & ETF Price Forecast - Intellectia AI
OptimizeRx (OPRX) Jumps 5.9%: Does the Stock Have More Room to Grow? - Bitget
Earnings call transcript: OptimizeRx Q4 2025 earnings beat forecasts, stock dips - Investing.com Australia
OPRX SEC FilingsOptimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan
OptimizeRx (OPRX) Soars 5.9%: Is Further Upside Left in the Stock? - finance.yahoo.com
Best Value Stocks to Buy for March 24th - sharewise.com
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates - msn.com
Strength seen in OptimizeRx (OPRX): Can its 7.5% jump turn into more strength? - MSN
Guidance Update: Can OptimizeRx Corporation sustain earnings growthEntry Point & Fast Entry Momentum Alerts - baoquankhu1.vn
OPRX Technical Analysis & Stock Price Forecast - Intellectia AI
How The OptimizeRx (OPRX) Narrative Is Shifting As Guidance Resets And Valuation Expectations Reprice - Yahoo Finance
OptimizeRx Corp. (NASDAQ:OPRX) Short Interest Down 16.4% in February - MarketBeat
Is OptimizeRx (OPRX) Stock Undervalued Right Now? - Yahoo Finance
Best Value Stocks to Buy for March 16th - The Globe and Mail
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - MSN
OptimizeRx Corp. (OPRX) Q4 earnings and revenues beat estimates - MSN
OptimizeRx (OPRX) outlines AI-driven pharma marketing strategy and key risks - Stock Titan
Should you sell your OptimizeRx stock? - Cantech Letter
OptimizeRx Corporation Common Stock OPRX ) Stock Price Today & Analysis - Gotrade
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
OptimizeRx (OPRX) Q4 Profitability Turn Challenges Skeptical Earnings Narratives - simplywall.st
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $20.00 by Analysts at Lake Street Capital - MarketBeat
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $18.00 by Analysts at Roth Mkm - MarketBeat
OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty - Bitget
Assessing OptimizeRx: Insights From 4 Financial Analysts - Benzinga
B. Riley Financial Reaffirms Buy Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat
OptimizeRx (OPRX) Target Price Lowered by Stephens & Co. | OPRX Stock News - GuruFocus
Stephens Cuts OptimizeRx (NASDAQ:OPRX) Price Target to $10.00 - MarketBeat
OptimizeRx (NASDAQ:OPRX) Announces Quarterly Earnings Results - MarketBeat
Stephens cuts OptimizeRx stock price target on soft pharma budgets - Investing.com Nigeria
OptimizeRx Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript - AOL.com
Stephens cuts OptimizeRx stock price target on soft pharma budgets By Investing.com - Investing.com UK
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
OptimizeRx Corp (OPRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
0.66%
3.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):